0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Vascular Embolization Agent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-2D13682
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Vascular Embolization Agent Market Insights Forecast to 2029
BUY CHAPTERS

Vascular Embolization Agent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-2D13682
Report
October 2024
Pages:161
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vascular Embolization Agent - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Vascular Embolization Agent - Market

Vascular Embolization Agent - Market

The global market for Vascular Embolization Agent was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vascular Embolization Agent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Vascular Embolization Agent by region & country, by Type, and by Application.
The Vascular Embolization Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vascular Embolization Agent.
Market Segmentation

Scope of Vascular Embolization Agent - Market Report

Report Metric Details
Report Name Vascular Embolization Agent - Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type:
  • Temporary
  • Permanent
Segment by Application
  • Hospital
  • Ambulatory Surgery Center
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC, Stryker, Guerbet LLC, Terumo Corporation, Penumbra, Grandpharma (Sirtex), Merit Medical, Siemens Healthineers (Varian), Jiangsu Hengrui Medicine, Kaneka, Meril Life Sciences, Peijia Medical, Wallaby Medical, MicroPort Scientific Corporation, Weihai Visee Medical Devices, Beijing Taijieweiye Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Vascular Embolization Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Vascular Embolization Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Vascular Embolization Agent in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Vascular Embolization Agent - Market report?

Ans: The main players in the Vascular Embolization Agent - Market are Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC, Stryker, Guerbet LLC, Terumo Corporation, Penumbra, Grandpharma (Sirtex), Merit Medical, Siemens Healthineers (Varian), Jiangsu Hengrui Medicine, Kaneka, Meril Life Sciences, Peijia Medical, Wallaby Medical, MicroPort Scientific Corporation, Weihai Visee Medical Devices, Beijing Taijieweiye Technology

What are the Application segmentation covered in the Vascular Embolization Agent - Market report?

Ans: The Applications covered in the Vascular Embolization Agent - Market report are Hospital, Ambulatory Surgery Center

What are the Type segmentation covered in the Vascular Embolization Agent - Market report?

Ans: The Types covered in the Vascular Embolization Agent - Market report are Temporary, Permanent

1 Market Overview
1.1 Vascular Embolization Agent Product Introduction
1.2 Global Vascular Embolization Agent Market Size Forecast
1.2.1 Global Vascular Embolization Agent Sales Value (2019-2030)
1.2.2 Global Vascular Embolization Agent Sales Volume (2019-2030)
1.2.3 Global Vascular Embolization Agent Sales Price (2019-2030)
1.3 Vascular Embolization Agent Market Trends & Drivers
1.3.1 Vascular Embolization Agent Industry Trends
1.3.2 Vascular Embolization Agent Market Drivers & Opportunity
1.3.3 Vascular Embolization Agent Market Challenges
1.3.4 Vascular Embolization Agent Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Vascular Embolization Agent Players Revenue Ranking (2023)
2.2 Global Vascular Embolization Agent Revenue by Company (2019-2024)
2.3 Global Vascular Embolization Agent Players Sales Volume Ranking (2023)
2.4 Global Vascular Embolization Agent Sales Volume by Company Players (2019-2024)
2.5 Global Vascular Embolization Agent Average Price by Company (2019-2024)
2.6 Key Manufacturers Vascular Embolization Agent Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Vascular Embolization Agent Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Vascular Embolization Agent
2.9 Vascular Embolization Agent Market Competitive Analysis
2.9.1 Vascular Embolization Agent Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Vascular Embolization Agent Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Embolization Agent as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Temporary
3.1.2 Permanent
3.2 Global Vascular Embolization Agent Sales Value by Type
3.2.1 Global Vascular Embolization Agent Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Vascular Embolization Agent Sales Value, by Type (2019-2030)
3.2.3 Global Vascular Embolization Agent Sales Value, by Type (%) (2019-2030)
3.3 Global Vascular Embolization Agent Sales Volume by Type
3.3.1 Global Vascular Embolization Agent Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Vascular Embolization Agent Sales Volume, by Type (2019-2030)
3.3.3 Global Vascular Embolization Agent Sales Volume, by Type (%) (2019-2030)
3.4 Global Vascular Embolization Agent Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Ambulatory Surgery Center
4.2 Global Vascular Embolization Agent Sales Value by Application
4.2.1 Global Vascular Embolization Agent Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Vascular Embolization Agent Sales Value, by Application (2019-2030)
4.2.3 Global Vascular Embolization Agent Sales Value, by Application (%) (2019-2030)
4.3 Global Vascular Embolization Agent Sales Volume by Application
4.3.1 Global Vascular Embolization Agent Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Vascular Embolization Agent Sales Volume, by Application (2019-2030)
4.3.3 Global Vascular Embolization Agent Sales Volume, by Application (%) (2019-2030)
4.4 Global Vascular Embolization Agent Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Vascular Embolization Agent Sales Value by Region
5.1.1 Global Vascular Embolization Agent Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Vascular Embolization Agent Sales Value by Region (2019-2024)
5.1.3 Global Vascular Embolization Agent Sales Value by Region (2025-2030)
5.1.4 Global Vascular Embolization Agent Sales Value by Region (%), (2019-2030)
5.2 Global Vascular Embolization Agent Sales Volume by Region
5.2.1 Global Vascular Embolization Agent Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Vascular Embolization Agent Sales Volume by Region (2019-2024)
5.2.3 Global Vascular Embolization Agent Sales Volume by Region (2025-2030)
5.2.4 Global Vascular Embolization Agent Sales Volume by Region (%), (2019-2030)
5.3 Global Vascular Embolization Agent Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Vascular Embolization Agent Sales Value, 2019-2030
5.4.2 North America Vascular Embolization Agent Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Vascular Embolization Agent Sales Value, 2019-2030
5.5.2 Europe Vascular Embolization Agent Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Vascular Embolization Agent Sales Value, 2019-2030
5.6.2 Asia Pacific Vascular Embolization Agent Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Vascular Embolization Agent Sales Value, 2019-2030
5.7.2 South America Vascular Embolization Agent Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Vascular Embolization Agent Sales Value, 2019-2030
5.8.2 Middle East & Africa Vascular Embolization Agent Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Vascular Embolization Agent Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Vascular Embolization Agent Sales Value
6.2.1 Key Countries/Regions Vascular Embolization Agent Sales Value, 2019-2030
6.2.2 Key Countries/Regions Vascular Embolization Agent Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Vascular Embolization Agent Sales Value, 2019-2030
6.3.2 United States Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Vascular Embolization Agent Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Vascular Embolization Agent Sales Value, 2019-2030
6.4.2 Europe Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Vascular Embolization Agent Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Vascular Embolization Agent Sales Value, 2019-2030
6.5.2 China Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
6.5.3 China Vascular Embolization Agent Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Vascular Embolization Agent Sales Value, 2019-2030
6.6.2 Japan Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Vascular Embolization Agent Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Vascular Embolization Agent Sales Value, 2019-2030
6.7.2 South Korea Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Vascular Embolization Agent Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Vascular Embolization Agent Sales Value, 2019-2030
6.8.2 Southeast Asia Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Vascular Embolization Agent Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Vascular Embolization Agent Sales Value, 2019-2030
6.9.2 India Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
6.9.3 India Vascular Embolization Agent Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Vascular Embolization Agent Product Offerings
7.1.5 Abbott Recent Development
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific Corporation Company Information
7.2.2 Boston Scientific Corporation Introduction and Business Overview
7.2.3 Boston Scientific Corporation Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boston Scientific Corporation Vascular Embolization Agent Product Offerings
7.2.5 Boston Scientific Corporation Recent Development
7.3 Cook Medical LLC
7.3.1 Cook Medical LLC Company Information
7.3.2 Cook Medical LLC Introduction and Business Overview
7.3.3 Cook Medical LLC Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Cook Medical LLC Vascular Embolization Agent Product Offerings
7.3.5 Cook Medical LLC Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Information
7.4.2 Johnson & Johnson Introduction and Business Overview
7.4.3 Johnson & Johnson Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Johnson & Johnson Vascular Embolization Agent Product Offerings
7.4.5 Johnson & Johnson Recent Development
7.5 Medtronic
7.5.1 Medtronic Company Information
7.5.2 Medtronic Introduction and Business Overview
7.5.3 Medtronic Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Medtronic Vascular Embolization Agent Product Offerings
7.5.5 Medtronic Recent Development
7.6 Acandis GmbH
7.6.1 Acandis GmbH Company Information
7.6.2 Acandis GmbH Introduction and Business Overview
7.6.3 Acandis GmbH Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Acandis GmbH Vascular Embolization Agent Product Offerings
7.6.5 Acandis GmbH Recent Development
7.7 SSEM Mthembu Medical (Pty) Ltd
7.7.1 SSEM Mthembu Medical (Pty) Ltd Company Information
7.7.2 SSEM Mthembu Medical (Pty) Ltd Introduction and Business Overview
7.7.3 SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.7.4 SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Product Offerings
7.7.5 SSEM Mthembu Medical (Pty) Ltd Recent Development
7.8 Balt USA LLC
7.8.1 Balt USA LLC Company Information
7.8.2 Balt USA LLC Introduction and Business Overview
7.8.3 Balt USA LLC Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Balt USA LLC Vascular Embolization Agent Product Offerings
7.8.5 Balt USA LLC Recent Development
7.9 Stryker
7.9.1 Stryker Company Information
7.9.2 Stryker Introduction and Business Overview
7.9.3 Stryker Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Stryker Vascular Embolization Agent Product Offerings
7.9.5 Stryker Recent Development
7.10 Guerbet LLC
7.10.1 Guerbet LLC Company Information
7.10.2 Guerbet LLC Introduction and Business Overview
7.10.3 Guerbet LLC Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Guerbet LLC Vascular Embolization Agent Product Offerings
7.10.5 Guerbet LLC Recent Development
7.11 Terumo Corporation
7.11.1 Terumo Corporation Company Information
7.11.2 Terumo Corporation Introduction and Business Overview
7.11.3 Terumo Corporation Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Terumo Corporation Vascular Embolization Agent Product Offerings
7.11.5 Terumo Corporation Recent Development
7.12 Penumbra
7.12.1 Penumbra Company Information
7.12.2 Penumbra Introduction and Business Overview
7.12.3 Penumbra Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Penumbra Vascular Embolization Agent Product Offerings
7.12.5 Penumbra Recent Development
7.13 Grandpharma (Sirtex)
7.13.1 Grandpharma (Sirtex) Company Information
7.13.2 Grandpharma (Sirtex) Introduction and Business Overview
7.13.3 Grandpharma (Sirtex) Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Grandpharma (Sirtex) Vascular Embolization Agent Product Offerings
7.13.5 Grandpharma (Sirtex) Recent Development
7.14 Merit Medical
7.14.1 Merit Medical Company Information
7.14.2 Merit Medical Introduction and Business Overview
7.14.3 Merit Medical Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Merit Medical Vascular Embolization Agent Product Offerings
7.14.5 Merit Medical Recent Development
7.15 Siemens Healthineers (Varian)
7.15.1 Siemens Healthineers (Varian) Company Information
7.15.2 Siemens Healthineers (Varian) Introduction and Business Overview
7.15.3 Siemens Healthineers (Varian) Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Siemens Healthineers (Varian) Vascular Embolization Agent Product Offerings
7.15.5 Siemens Healthineers (Varian) Recent Development
7.16 Jiangsu Hengrui Medicine
7.16.1 Jiangsu Hengrui Medicine Company Information
7.16.2 Jiangsu Hengrui Medicine Introduction and Business Overview
7.16.3 Jiangsu Hengrui Medicine Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Jiangsu Hengrui Medicine Vascular Embolization Agent Product Offerings
7.16.5 Jiangsu Hengrui Medicine Recent Development
7.17 Kaneka
7.17.1 Kaneka Company Information
7.17.2 Kaneka Introduction and Business Overview
7.17.3 Kaneka Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Kaneka Vascular Embolization Agent Product Offerings
7.17.5 Kaneka Recent Development
7.18 Meril Life Sciences
7.18.1 Meril Life Sciences Company Information
7.18.2 Meril Life Sciences Introduction and Business Overview
7.18.3 Meril Life Sciences Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Meril Life Sciences Vascular Embolization Agent Product Offerings
7.18.5 Meril Life Sciences Recent Development
7.19 Peijia Medical
7.19.1 Peijia Medical Company Information
7.19.2 Peijia Medical Introduction and Business Overview
7.19.3 Peijia Medical Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Peijia Medical Vascular Embolization Agent Product Offerings
7.19.5 Peijia Medical Recent Development
7.20 Wallaby Medical
7.20.1 Wallaby Medical Company Information
7.20.2 Wallaby Medical Introduction and Business Overview
7.20.3 Wallaby Medical Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Wallaby Medical Vascular Embolization Agent Product Offerings
7.20.5 Wallaby Medical Recent Development
7.21 MicroPort Scientific Corporation
7.21.1 MicroPort Scientific Corporation Company Information
7.21.2 MicroPort Scientific Corporation Introduction and Business Overview
7.21.3 MicroPort Scientific Corporation Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.21.4 MicroPort Scientific Corporation Vascular Embolization Agent Product Offerings
7.21.5 MicroPort Scientific Corporation Recent Development
7.22 Weihai Visee Medical Devices
7.22.1 Weihai Visee Medical Devices Company Information
7.22.2 Weihai Visee Medical Devices Introduction and Business Overview
7.22.3 Weihai Visee Medical Devices Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Weihai Visee Medical Devices Vascular Embolization Agent Product Offerings
7.22.5 Weihai Visee Medical Devices Recent Development
7.23 Beijing Taijieweiye Technology
7.23.1 Beijing Taijieweiye Technology Company Information
7.23.2 Beijing Taijieweiye Technology Introduction and Business Overview
7.23.3 Beijing Taijieweiye Technology Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Beijing Taijieweiye Technology Vascular Embolization Agent Product Offerings
7.23.5 Beijing Taijieweiye Technology Recent Development
8 Industry Chain Analysis
8.1 Vascular Embolization Agent Industrial Chain
8.2 Vascular Embolization Agent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Vascular Embolization Agent Sales Model
8.5.2 Sales Channel
8.5.3 Vascular Embolization Agent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Vascular Embolization Agent Market Trends
    Table 2. Vascular Embolization Agent Market Drivers & Opportunity
    Table 3. Vascular Embolization Agent Market Challenges
    Table 4. Vascular Embolization Agent Market Restraints
    Table 5. Global Vascular Embolization Agent Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Vascular Embolization Agent Revenue Market Share by Company (2019-2024)
    Table 7. Global Vascular Embolization Agent Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Vascular Embolization Agent Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Vascular Embolization Agent Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Vascular Embolization Agent Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Vascular Embolization Agent Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Vascular Embolization Agent
    Table 13. Global Vascular Embolization Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Embolization Agent as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Vascular Embolization Agent Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Vascular Embolization Agent Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Vascular Embolization Agent Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Vascular Embolization Agent Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Vascular Embolization Agent Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Vascular Embolization Agent Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Vascular Embolization Agent Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Vascular Embolization Agent Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Vascular Embolization Agent Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Vascular Embolization Agent Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Vascular Embolization Agent Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Vascular Embolization Agent Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Vascular Embolization Agent Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Vascular Embolization Agent Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Vascular Embolization Agent Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Vascular Embolization Agent Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Vascular Embolization Agent Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Vascular Embolization Agent Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Vascular Embolization Agent Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Vascular Embolization Agent Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Vascular Embolization Agent Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Vascular Embolization Agent Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Vascular Embolization Agent Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Vascular Embolization Agent Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Vascular Embolization Agent Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Vascular Embolization Agent Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Vascular Embolization Agent Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Vascular Embolization Agent Sales Value by Region (2019-2024) & (%)
    Table 44. Global Vascular Embolization Agent Sales Value by Region (2025-2030) & (%)
    Table 45. Global Vascular Embolization Agent Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Vascular Embolization Agent Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Vascular Embolization Agent Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Vascular Embolization Agent Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Vascular Embolization Agent Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Vascular Embolization Agent Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Vascular Embolization Agent Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Vascular Embolization Agent Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Vascular Embolization Agent Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Vascular Embolization Agent Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Vascular Embolization Agent Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Vascular Embolization Agent Sales Volume, (2025-2030) & (K Units)
    Table 57. Abbott Company Information
    Table 58. Abbott Introduction and Business Overview
    Table 59. Abbott Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Abbott Vascular Embolization Agent Product Offerings
    Table 61. Abbott Recent Development
    Table 62. Boston Scientific Corporation Company Information
    Table 63. Boston Scientific Corporation Introduction and Business Overview
    Table 64. Boston Scientific Corporation Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Boston Scientific Corporation Vascular Embolization Agent Product Offerings
    Table 66. Boston Scientific Corporation Recent Development
    Table 67. Cook Medical LLC Company Information
    Table 68. Cook Medical LLC Introduction and Business Overview
    Table 69. Cook Medical LLC Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Cook Medical LLC Vascular Embolization Agent Product Offerings
    Table 71. Cook Medical LLC Recent Development
    Table 72. Johnson & Johnson Company Information
    Table 73. Johnson & Johnson Introduction and Business Overview
    Table 74. Johnson & Johnson Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Johnson & Johnson Vascular Embolization Agent Product Offerings
    Table 76. Johnson & Johnson Recent Development
    Table 77. Medtronic Company Information
    Table 78. Medtronic Introduction and Business Overview
    Table 79. Medtronic Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Medtronic Vascular Embolization Agent Product Offerings
    Table 81. Medtronic Recent Development
    Table 82. Acandis GmbH Company Information
    Table 83. Acandis GmbH Introduction and Business Overview
    Table 84. Acandis GmbH Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Acandis GmbH Vascular Embolization Agent Product Offerings
    Table 86. Acandis GmbH Recent Development
    Table 87. SSEM Mthembu Medical (Pty) Ltd Company Information
    Table 88. SSEM Mthembu Medical (Pty) Ltd Introduction and Business Overview
    Table 89. SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Product Offerings
    Table 91. SSEM Mthembu Medical (Pty) Ltd Recent Development
    Table 92. Balt USA LLC Company Information
    Table 93. Balt USA LLC Introduction and Business Overview
    Table 94. Balt USA LLC Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Balt USA LLC Vascular Embolization Agent Product Offerings
    Table 96. Balt USA LLC Recent Development
    Table 97. Stryker Company Information
    Table 98. Stryker Introduction and Business Overview
    Table 99. Stryker Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Stryker Vascular Embolization Agent Product Offerings
    Table 101. Stryker Recent Development
    Table 102. Guerbet LLC Company Information
    Table 103. Guerbet LLC Introduction and Business Overview
    Table 104. Guerbet LLC Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Guerbet LLC Vascular Embolization Agent Product Offerings
    Table 106. Guerbet LLC Recent Development
    Table 107. Terumo Corporation Company Information
    Table 108. Terumo Corporation Introduction and Business Overview
    Table 109. Terumo Corporation Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Terumo Corporation Vascular Embolization Agent Product Offerings
    Table 111. Terumo Corporation Recent Development
    Table 112. Penumbra Company Information
    Table 113. Penumbra Introduction and Business Overview
    Table 114. Penumbra Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Penumbra Vascular Embolization Agent Product Offerings
    Table 116. Penumbra Recent Development
    Table 117. Grandpharma (Sirtex) Company Information
    Table 118. Grandpharma (Sirtex) Introduction and Business Overview
    Table 119. Grandpharma (Sirtex) Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Grandpharma (Sirtex) Vascular Embolization Agent Product Offerings
    Table 121. Grandpharma (Sirtex) Recent Development
    Table 122. Merit Medical Company Information
    Table 123. Merit Medical Introduction and Business Overview
    Table 124. Merit Medical Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Merit Medical Vascular Embolization Agent Product Offerings
    Table 126. Merit Medical Recent Development
    Table 127. Siemens Healthineers (Varian) Company Information
    Table 128. Siemens Healthineers (Varian) Introduction and Business Overview
    Table 129. Siemens Healthineers (Varian) Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Siemens Healthineers (Varian) Vascular Embolization Agent Product Offerings
    Table 131. Siemens Healthineers (Varian) Recent Development
    Table 132. Jiangsu Hengrui Medicine Company Information
    Table 133. Jiangsu Hengrui Medicine Introduction and Business Overview
    Table 134. Jiangsu Hengrui Medicine Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Jiangsu Hengrui Medicine Vascular Embolization Agent Product Offerings
    Table 136. Jiangsu Hengrui Medicine Recent Development
    Table 137. Kaneka Company Information
    Table 138. Kaneka Introduction and Business Overview
    Table 139. Kaneka Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Kaneka Vascular Embolization Agent Product Offerings
    Table 141. Kaneka Recent Development
    Table 142. Meril Life Sciences Company Information
    Table 143. Meril Life Sciences Introduction and Business Overview
    Table 144. Meril Life Sciences Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Meril Life Sciences Vascular Embolization Agent Product Offerings
    Table 146. Meril Life Sciences Recent Development
    Table 147. Peijia Medical Company Information
    Table 148. Peijia Medical Introduction and Business Overview
    Table 149. Peijia Medical Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Peijia Medical Vascular Embolization Agent Product Offerings
    Table 151. Peijia Medical Recent Development
    Table 152. Wallaby Medical Company Information
    Table 153. Wallaby Medical Introduction and Business Overview
    Table 154. Wallaby Medical Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Wallaby Medical Vascular Embolization Agent Product Offerings
    Table 156. Wallaby Medical Recent Development
    Table 157. MicroPort Scientific Corporation Company Information
    Table 158. MicroPort Scientific Corporation Introduction and Business Overview
    Table 159. MicroPort Scientific Corporation Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. MicroPort Scientific Corporation Vascular Embolization Agent Product Offerings
    Table 161. MicroPort Scientific Corporation Recent Development
    Table 162. Weihai Visee Medical Devices Company Information
    Table 163. Weihai Visee Medical Devices Introduction and Business Overview
    Table 164. Weihai Visee Medical Devices Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. Weihai Visee Medical Devices Vascular Embolization Agent Product Offerings
    Table 166. Weihai Visee Medical Devices Recent Development
    Table 167. Beijing Taijieweiye Technology Company Information
    Table 168. Beijing Taijieweiye Technology Introduction and Business Overview
    Table 169. Beijing Taijieweiye Technology Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. Beijing Taijieweiye Technology Vascular Embolization Agent Product Offerings
    Table 171. Beijing Taijieweiye Technology Recent Development
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Vascular Embolization Agent Downstream Customers
    Table 175. Vascular Embolization Agent Distributors List
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vascular Embolization Agent Product Picture
    Figure 2. Global Vascular Embolization Agent Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Vascular Embolization Agent Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Vascular Embolization Agent Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Vascular Embolization Agent Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Vascular Embolization Agent Report Years Considered
    Figure 7. Global Vascular Embolization Agent Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Vascular Embolization Agent Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Vascular Embolization Agent Revenue in 2023
    Figure 10. Vascular Embolization Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Temporary Picture
    Figure 12. Permanent Picture
    Figure 13. Global Vascular Embolization Agent Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Vascular Embolization Agent Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Vascular Embolization Agent Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Vascular Embolization Agent Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Vascular Embolization Agent Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Ambulatory Surgery Center
    Figure 20. Global Vascular Embolization Agent Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Vascular Embolization Agent Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Vascular Embolization Agent Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Vascular Embolization Agent Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Vascular Embolization Agent Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Vascular Embolization Agent Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Vascular Embolization Agent Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Vascular Embolization Agent Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Vascular Embolization Agent Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Vascular Embolization Agent Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Vascular Embolization Agent Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Vascular Embolization Agent Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Vascular Embolization Agent Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Vascular Embolization Agent Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Vascular Embolization Agent Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Vascular Embolization Agent Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Vascular Embolization Agent Sales Volume (%), (2019-2030)
    Figure 37. United States Vascular Embolization Agent Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Vascular Embolization Agent Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Vascular Embolization Agent Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Vascular Embolization Agent Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Vascular Embolization Agent Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Vascular Embolization Agent Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Vascular Embolization Agent Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Vascular Embolization Agent Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Vascular Embolization Agent Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Vascular Embolization Agent Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Vascular Embolization Agent Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Vascular Embolization Agent Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Vascular Embolization Agent Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Vascular Embolization Agent Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Vascular Embolization Agent Sales Value by Application (%), 2023 VS 2030
    Figure 58. Vascular Embolization Agent Industrial Chain
    Figure 59. Vascular Embolization Agent Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Add to Cart

Add to Cart

Dual Chamber Temporary Pacemaker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-35Y14435
Tue Nov 12 00:00:00 UTC 2024

Add to Cart

Hemodynamic Altering Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-36L13936
Wed Nov 06 00:00:00 UTC 2024

Add to Cart